Latest News About - Veterinary Products

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Thursday, January 23, 2020

11:55:00 PM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Matthieu Frechin said: "We achieved a solid second semester and our annual performance is the result of our focused strategy and the acquisition in Brazil. This is reflected in the continued growth in Essentials sales across all strategic territories. The integration of Clarion in Brazil is progressing according to plan, while we continue to work on reorganizing our production facilities in Europe. We therefore look forward to 2020 with confidence in our plans to invest and secure sustainable long-term growth for our Group" External link

finanznachrichten-en Thursday, January 23, 2020 6:01:00 PM CET

Janet Woodcock said: “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” External link

fda Friday, January 10, 2020 9:43:00 PM CET

Richard Pazdur said: “GIST harboring a PDGFRA exon 18 mutation do not respond to standard therapies for GIST. However, today’s approval provides patients with the first drug specifically approved for GIST harboring this mutation,” External link

fda Thursday, January 9, 2020 9:42:00 PM CET

Janet Woodcock said: “By providing comprehensive, accessible learning tools, we will support outsourcing facilities in reliably producing high-quality compounded products that meet FDA’s standards. While engagement is voluntary, this initiative will provide an increased awareness and understanding of common issues and provide innovative ways to address challenges outsourcing facilities may face,” External link

fda Tuesday, December 24, 2019 8:09:00 AM CET

Alberto Gutiérrez said: "The FDA works hard to help ensure that novel technologies, which can reduce the burden of daily disease management, are safe and accurate," External link

fda Tuesday, December 24, 2019 8:09:00 AM CET

Richard Pazdur said: “There have been many advances in the development of drugs for HER2-positive breast cancer since the introduction of Herceptin (trastuzumab) in 1998. The approval of Enhertu represents the newest treatment option for patients who have progressed on available HER2-directed therapies,” External link

fda Tuesday, December 24, 2019 8:09:00 AM CET

Anna Abram said: “While the risk of Ebola virus disease in the U.S. remains low, the U.S. government remains deeply committed to fighting devastating Ebola outbreaks in Africa, including the current outbreak in the Democratic Republic of the Congo,” External link

fda Tuesday, December 24, 2019 8:09:00 AM CET

Peter Marks said: “Ebola virus disease is a rare but severe and often deadly disease that knows no borders. Vaccination is essential to help prevent outbreaks and to stop the Ebola virus from spreading when outbreaks do occur,” External link

fda Tuesday, December 24, 2019 8:09:00 AM CET

Richard Pazdur said: “Antibody-drug conjugates are strategic tools in the targeted treatment of cancer. These conjugates combine the ability of monoclonal antibodies to target specific receptors on cancer cells and then deliver a drug to the cancer cell,” External link

fda Tuesday, December 24, 2019 8:09:00 AM CET

Janet Woodcock said: “Today’s approvals of the first generics of apixaban are an example of how the FDA’s generic drug program improves access to lower-cost, safe and high-quality medicines,” External link

fda Monday, December 23, 2019 8:56:00 PM CET

Billy Dunn said: “Migraine is an often disabling condition that affects an estimated 37 million people in the U.S.,” External link

fda Monday, December 23, 2019 8:56:00 PM CET

Peter Marks said: “As the new school year is getting underway across the nation, the FDA would like to remind parents and caregivers about the importance of making sure children are up to date on their vaccines. We cannot state strongly enough that overwhelming scientific evidence shows that vaccines are among the most effective and safest interventions, to both prevent individual illness and protect public health,” External link

fda Saturday, December 21, 2019 5:42:00 PM CET

Janet Woodcock said: “Prescription central nervous system stimulants are medicines that are used for the treatment of attention deficit hyperactivity disorder and, in some cases, narcolepsy. When used appropriately, prescription stimulants can provide significant benefits for patients. However, these drugs can also be abused, and the FDA recognizes this is an important public health concern,” External link

fda Saturday, December 21, 2019 5:42:00 PM CET

Alberto Gutiérrez said: "The FDA works hard to help ensure that novel technologies, which can reduce the burden of daily disease management, are safe and accurate," External link

fda Friday, December 20, 2019 10:05:00 PM CET

Richard Pazdur said: “There have been many advances in the development of drugs for HER2-positive breast cancer since the introduction of Herceptin (trastuzumab) in 1998. The approval of Enhertu represents the newest treatment option for patients who have progressed on available HER2-directed therapies,” External link

fda Friday, December 20, 2019 8:05:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.